Peach; Robert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Peach; Robert J..The latest application filed is for "methods of treatment using ctla4 mutant molecules".

Company Profile

0.6.15

Peach; Robert J. - San Diego CA
Peach, Robert J. - Southampton PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treatment Using Ctla4 Mutant Molecules App 20120052065 - Peach; Robert J. ; et al.	2012-03-01
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant 7,829,534 - Larsen , et al. November 9, 2	2010-11-09
Methods Of Treatment Using Ctla4 Mutant Molecules App 20100183612 - Peach; Robert J. ; et al.	2010-07-22
Methods of treatment using CTLA4 mutant molecules App 20090041769 - Peach; Robert J. ; et al.	2009-02-12
Methods of treatment using CTLA4 mutant molecules Grant 7,439,230 - Peach , et al. October 21, 2	2008-10-21
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules App 20080160022 - Larsen; Christian P. ; et al.	2008-07-03
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant 7,304,033 - Larsen , et al. December 4, 2	2007-12-04
Polynucleotides encoding novel isoforms of IGSF9 App 20070071674 - McLachlan; Karen ; et al.	2007-03-29
Soluble CTLA4 mutant molecules and uses thereof Grant 7,105,166 - Linsley , et al. September 12, 2	2006-09-12
Soluble CTLA4 mutant molecules Grant 7,094,874 - Peach , et al. August 22, 2	2006-08-22
B7-related nucleic acids and polypeptides useful for immunomodulation App 20060140937 - Mikesell; Glen E. ; et al.	2006-06-29
Antibodies directed to B7-related polypeptide, BSL-2 Grant 6,965,018 - Mikesell , et al. November 15, 2	2005-11-15
Soluble CTLA4 mutant molecules and uses thereof App 20050214313 - Peach, Robert J. ; et al.	2005-09-29
Polynucleotides encoding B7-related nucleic acid, BSL2vcvc-Ig App 20050208525 - Mikesell, Glen E. ; et al.	2005-09-22
Compositions and methods for treating cancer using IGSF9 and LIV-1 App 20040258616 - McLachlan, Karen ; et al.	2004-12-23
Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID App 20040022787 - Cohen, Robert ; et al.	2004-02-05
Soluble CTLA4 mutant molecules and uses thereof App 20030219863 - Peach, Robert J. ; et al.	2003-11-27
Methods for treating rheumatic diseases using a soluble CTLA4 molecule App 20030083246 - Cohen, Robert ; et al.	2003-05-01
Soluble CTLA4 mutant molecules and uses thereof App 20020182211 - Peach, Robert J. ; et al.	2002-12-05
B7-related nucleic acids and polypeptides useful for immunomodulation App 20020095024 - Mikesell, Glen E. ; et al.	2002-07-18
Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes App 20020039577 - Townsend, Robert M. ; et al.	2002-04-04

Company Registrations

SEC

0001575203

Peach Robert J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.